((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate

Catalog No. :
ACBPIV854
CAS No. :
491-97-4
Molecular Formula :
C10H16N2O11P2
Molecular Weight :
402.19

IUPAC Name:((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate

((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate
IUPAC Name((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate
Molecular FormulaC10H16N2O11P2
Molecular Weight402.19
SMILESO=C1N(C=C(C(N1)=O)C)[C@]2([H])O[C@@H]([C@H](C2)O)COP(OP(O)(O)=O)(O)=O
InChI KeyUJLXYODCHAELLY-XLPZGREQSA-N
Synonym5'-TDP;Thymidine 5'-pyrophosphate;Thymidine diphosphate;Thymidine pyrophosphate;Deoxy-tdp;Thymidine 5'-(trihydrogen diphosphate) (9ci);[hydroxy-[[3-hydroxy-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-oxolan-2-yl]methoxy]phosphoryl]oxyphosphonic acid;Thymidine 5'-(trihydrogen diphosphate)
CAS No.491-97-4

Synthetic Route by SureRoute

1. ACBPIV854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBPIV854 route product structure diagram
    ACBPIV854491-97-4
Inquiry

2. ACBPIV854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADFE105 route compound structure diagram
    ACADFE10595648-78-5 In Stock
  2. Then
  3. ACBPIV854 route product structure diagram
    ACBPIV854491-97-4
Inquiry

Comments (0)